Vivos Therapeutics Inc (VVOS) 財務データ
*すべての数値は百万単位です
| 期間終了日 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|---|
| 期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
| Revenues | 0.23%5.15 | 5.14 | 3.82 | 6.78 | 3.82 |
| Gross Profit | 3.47%2.95 | 3.06 | 2.99 | 3.94 | 2.11 |
| Operating Expenses | 19.60%7.78 | 9.67 | 9.37 | 8.67 | 6.98 |
| Interest Income/Expense | 1.10 | 1.10 | 0.80 | 0.50 | - |
| Depreciation and Amortization | 12.33%0.51 | 0.45 | 0.44 | 0.38 | 0.31 |
| Operating Income/Loss | 27.06%-4.83 | -6.62 | -6.38 | -4.73 | -4.87 |
| Income/Loss From Continuing Operations Before Tax | 28.74%-5.52 | -7.75 | -6.95 | -5.40 | -5.01 |
28.74%-5.52 | -7.75 | -6.89 | -5.40 | -5.01 | |
| Attributable To Parent | 28.65%-5.48 | -7.68 | -6.89 | -5.40 | -5.01 |
| Available To Common Stockholders, Basic | 28.65%-5.48 | -7.68 | -6.95 | -5.40 | -5.01 |
| Attributable To Noncontrolling Interest | 39.13%-0.04 | -0.07 | - | - | - |
| Basic Average Shares | 20.83%17.68 | 14.63 | - | 10.96 | 9.09 |
| Diluted Average Shares | 20.83%17.68 | 14.63 | - | 10.96 | 9.09 |
| Basic Earnings Per Share | 40.38%-0.31 | -0.52 | - | -0.49 | -0.55 |
| Diluted Earnings Per Share | 40.38%-0.31 | -0.52 | - | -0.49 | -0.55 |